A Multi-centre Randomized Controlled Trial to Assess Feasibility and Safety of Adjunctive Treatment With the HemoSystem REBOOT in Critically Ill patientS wiTh Sepsis-induced Immunosuppression
The aim of this randomized controlled trial is to restore immune function by selectively removing three mediators largely contributing to sepsis-induced immunosuppression from extracorporeal circulation.
100 Clinical Results associated with hemotune AG
0 Patents (Medical) associated with hemotune AG
100 Deals associated with hemotune AG
100 Translational Medicine associated with hemotune AG